Federal contractor · FRIENDSWOOD, TX
HALCYON BIOMEDICAL INC
HALCYON BIOMEDICAL INC received $600K in federal contract obligations in FY2026, on 1 awards. Its largest customer was Departmental Offices ($600K). It also received $351.9K in federal grants and other assistance in FY2026.
- Obligations · FY2026
- $600K
- New awards
- 1
- Sole-source
- 0.0%
- Single offer
- 0.0%
- UEI
- C15ACBHQ4P67
- Parent company
- HALCYON BIOMEDICAL INC
Spending by fiscal year
Obligations per federal fiscal year (October–September).
- 600KFY2026
Top buying agencies
Obligations in FY2026.
- Departmental Offices$600K100%1 awards
What was bought · Where the work was performed
Obligations in FY2026.
What was bought
- Research & development$600K100%
Where the work was performed
- Galveston County, TX$600K100%
Integrity signals
Shares of the year's obligations, next to the country's.
- Low competition0.0%US 39% · $0
- Sole-source awards0.0%US 30% · $0
- Single-offer competitions0.0%US 8.8% · $0
- Urgency justifications0.0%US 5.1% · $0
A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.
Largest awards
- TOPIC 4 SBIR$600KDepartmental Offices· Galveston County, TX· Research & development· Feb 25, 2026 – Jul 17, 2026· 140D0426C0009
Federal grants & assistance received
Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.
HALCYON BIOMEDICAL INC received $351.9K in federal assistance in FY2026, on 1 actions (1 new awards). Its largest program was 93.837 · Cardiovascular Diseases Research ($351.9K).
- Assistance · FY2026
- $351.9K
- New awards
- 1
- Actions
- 1
- Since FY2021
- $551.4K
Assistance by fiscal year
- 149.5KFY2021
- 50KFY2022
- 351.9KFY2026
By type
- Grants$351.9K100%
Top programs
- 93.837 · Cardiovascular Diseases Research$351.9K100%
Awarding agencies
- National Institutes of Health$351.9K100%Department of Health and Human Services
Largest awards
- 93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Sep 4, 2026 – Sep 4, 2026· R33HL183009
Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.
Competitors
Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.
Compared on 1 market (agency × industry), FY2024–FY2026.
- GT BIOSCIENCES, INC.$600KCAMBRIDGE, MA · 100.0% of this company's obligations are in markets they both serveDepartmental Offices · Scientific research and development services
- ZENSO INC$599.3KBERKELEY, CA · 99.9% of this company's obligations are in markets they both serveDepartmental Offices · Scientific research and development services
- WEST HOLLYWOOD, CA · 99.7% of this company's obligations are in markets they both serveDepartmental Offices · Scientific research and development services
Showing the top 3 of 25 competitors. Open the profile for the full list.
Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026 · FY2024–FY2026.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026.